Infermedica
3 known investors
Infermedica develops an AI-powered healthcare platform for symptom assessment, triage, and patient intake that integrates into clinical workflows to improve patient access to care. The platform serves healthcare providers and patients globally across 35 countries, supporting primary care and clinical decision-making across 26 languages.
Founders & leadership
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$10.2MraisedJul 2020 · 5 investors · Other TechnologyRule 506(b)
▶$10.2MraisedJul 2020 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mariia BarsukDirector
- Piotr OrzechowskiExecutive Officer, Director
- Michal RokoszDirector
- Margus UudamDirector
- Offering amount
- $10.2M
- Amount sold
- $10.2M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$3.7MraisedJun 2019 · 6 investors · Other TechnologyRule 506(b)
▶$3.7MraisedJun 2019 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michal RokoszDirector
- Margus UudamDirector
- Piotr OrzechowskiExecutive Officer, Director
- Offering amount
- $3.7M
- Amount sold
- $3.7M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Infermedica raises €26.5 million to expand AI-driven medical guidance platform | EU-Startupseu-startups.com · 2022
- Infermedica Raises $30 million Series B Funding from One Peak to Expand AI-driven Medical Guidance Platform | Healthcare IT Todayhealthcareittoday.com · 2022
- Infermedica raises $30M to expand its AI-based medical guidance platform | TechCrunchtechcrunch.com · 2022
- Infermedica raises $10.2 millioncoverager.com · 2020
- Infermedica announces $10.2M series A for triage, symptom checking system | MobiHealthNewsmobihealthnews.com · 2020
)